Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
SOMERSET, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 10, 2026, to review fourth-quarter and full-year 2025 financial results.
During the conference call and accompanying webcast, senior management will provide an overview of quarterly and full-year financial performance.
With over 2,900 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Just Handed Ripple (XRP) the Keys. Here’s What Happened
Is Grayscale Quietly Accumulating Hyperliquid? Arkham Flags $10M HYPE

Moody’s warns Indonesia commodity export plan a risk for miners, may distort market
This Mainstream Media Posted Bullish Trump Crypto Report With Ripple (XRP) Logo
